Advanced Stem Cell-Derived Therapy: NextGen Regenerative Solutions
ActiveRegistered as Micregen Ltd
Data to 4 Nov 2026, 01:59
- Company number
- 09714391
- Sector
- Health and life sciences
- SIC group
- Life sciences and health
- Region
- North West (Bolton)
- Incorporated
- 3 Aug 2015
- SIC code
- 72110
- Trading name
- Advanced Stem Cell-Derived Therapy: NextGen Regenerative Solutions
- Website
- micregen.com Legal name and address on the site, checked 19 Oct 2026
Advanced Stem Cell-Derived Therapy: NextGen Regenerative Solutions has 1 priced round on record from share allotment filings at Companies House. The latest was allotted on 22 Mar 2024, raised £681k, and was filed on 21 Aug 2024. Data to 3 Nov 2026.
1
Priced rounds
Allotted Mar 2024
£681k
Cash raised in those rounds
Sum of sterling cash raised in each round, as filed
22 Mar 2024
Latest round allotted
Filed 21 Aug 2024
Jump to
Funding rounds
Priced equity rounds read from share allotment filings at Companies House, newest first.
| Allotted | First filed | Cash raised | Filing |
|---|---|---|---|
| 22 Mar 2024to 11 Jun 2024Latest | 21 Aug 2024 | £681k | Open filing |
Companies with significant control
Companies with significant control over Advanced Stem Cell-Derived Therapy: NextGen Regenerative Solutions, from the register of people with significant control. A company can have control without holding shares. Individuals are not shown on public pages.
No corporate holder of 25% or more is registered.
From the PSC register.
Filings
The latest 6 capital filings other than share allotments (SH01), which are listed under Funding rounds. 12 share filings (SH01, SH02, SH08 and SH10) have been read for this company.
| Date | Filing | Document |
|---|---|---|
| 22 Dec 2023 | Resolution | Open at Companies House |
| 22 Dec 2023 | Memorandum and articles (MA) | Open at Companies House |
| 28 Mar 2023 | Resolution | Open at Companies House |
| 28 Mar 2023 | Resolution | Open at Companies House |
| 28 Mar 2023 | Memorandum and articles (MA) | Open at Companies House |
| 9 Jan 2022 | Resolution | Open at Companies House |
Documents open at Companies House. Bradshaw does not store or re-host them.
About this page
This page shows public register data for Advanced Stem Cell-Derived Therapy: NextGen Regenerative Solutions. Figures come from filings at Companies House; Bradshaw links to each filing and does not host copies. To correct or object to data about you, use the data request form.
Last updated 3 Nov 2026